Homology Medicines, Inc. (FIXX) Tops Q1 EPS by 2c

Homology Medicines, Inc. (NASDAQ: FIXX) reported Q1 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $867 thousand.

For earnings history and earnings-related data on Homology Medicines, Inc. (FIXX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Reading (RDI) Tops Q2 EPS by 4c